{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:08:52Z","timestamp":1789186132319,"version":"build-2803163510"},"reference-count":38,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.1253\/circrep.cr-26-0158","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:10:06Z","timestamp":1783548606000},"page":"1459-1469","source":"Crossref","is-referenced-by-count":0,"title":["Regional Myocardial Tissue Characterization by Cardiac Magnetic Resonance Is Associated With Heart Failure Development in Asymptomatic Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1253","volume":"8","author":[{"given":"Toshihiro","family":"Tsuruda","sequence":"first","affiliation":[{"name":"Department of Hemo-Vascular Advanced Medicine, Cardiorenal Research Laboratory, Faculty of Medicine, University of Miyazaki"},{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Suiko","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunosuke","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Komaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Moribayashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ideguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Ogata","sequence":"additional","affiliation":[{"name":"Heart Center, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Heart Center, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamasa","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Medicine of Sensory and Motor Organs, Division of Orthopaedic Surgery, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Nishihira","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art Review. <i>J Am Coll Cardiol<\/i> 2019; 73: 2872\u20132891, doi:10.1016\/j.jacc.2019.04.003.","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ioannou A, Patel RK, Razvi Y, Porcari A, Sinagra G, Venneri L, et al. Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years. <i>Circulation<\/i> 2022; 146: 1657\u20131670, doi:10.1161\/CIRCULATIONAHA.122.060852.","DOI":"10.1161\/CIRCULATIONAHA.122.060852"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Izumiya Y, Kuyama N, Hanatani S, Matsuzawa Y, Usuku H, Yamamoto E, et al. Real-world clinical evidence with tafamidis in patients with transthyretin amyloid cardiomyopathy: A contemporary review. <i>Circ Rep<\/i> 2025; 7: 599\u2013603, doi:10.1253\/circrep.CR-25-0092.","DOI":"10.1253\/circrep.CR-25-0092"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Quaggin-Smith JA, Wehbe RM, Holly TA. Incidental detection of ATTR cardiac amyloidosis. <i>J Nucl Cardiol<\/i> 2022; 29: 1030\u20131033, doi:10.1007\/s12350-020-02467-9.","DOI":"10.1007\/s12350-020-02467-9"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Kubota T, Kato S, Nagatomo D, Ishikita A, Nozoe M, Suematsu N. Real-world clinical impact of tafamidis on transthyretin amyloid cardiomyopathy: A decade of experience from a community-based hospital (2015\u20132024). <i>Circ Rep<\/i> 2025; 7: 442\u2013450, doi:10.1253\/circrep.CR-25-0031.","DOI":"10.1253\/circrep.CR-25-0031"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Minamisawa M, Konishi H, Kitano Y, Abe H, Togo K, Izumiya Y. Patient journey to transthyretin cardiac amyloidosis diagnosis: A Japanese claims database study. <i>Circ J<\/i> 2025; 89: 432\u2013441, doi:10.1253\/circj.CJ-24-0666.","DOI":"10.1253\/circj.CJ-24-0666"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Rapezzi C, Aimo A, Serenelli M, Barison A, Vergaro G, Passino C, et al. Critical comparison of documents from scientific societies on cardiac amyloidosis: JACC State-of-the-Art Review. <i>J Am Coll Cardiol<\/i> 2022; 79: 1288\u20131303, doi:10.1016\/j.jacc.2022.01.036.","DOI":"10.1016\/j.jacc.2022.01.036"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 Guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671, doi:10.1253\/circj.CJ-20-0110.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al. Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration. <i>JAMA Cardiol<\/i> 2025; 10: 437\u2013445, doi:10.1001\/jamacardio.2024.5221.","DOI":"10.1001\/jamacardio.2024.5221"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for multimodality imaging in cardiac amyloidosis. Part 1 of 2: Evidence base and standardized methods of imaging. <i>Circ Cardiovasc Imaging<\/i> 2021; 14: e000029, doi:10.1161\/HCI.0000000000000029.","DOI":"10.1161\/HCI.0000000000000029"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Pucci A, Aimo A, Musetti V, Barison A, Vergaro G, Genovesi D, et al. Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis. <i>J Am Heart Assoc<\/i> 2021; 10: e020358, doi:10.1161\/jaha.120.020358.","DOI":"10.1161\/JAHA.120.020358"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Ikegami Y, Kitagawa T, Sada Y, Okamoto D, Hamamoto K, Tatsugami F, et al. Myocardial T1 mapping, left ventricular parameters, and cardiac biomarkers in wild-type transthyretin amyloid cardiomyopathy before and after tafamidis treatment. <i>Circ Rep<\/i> 2025; 7: 198\u2013206, doi:10.1253\/circrep.CR-24-0170.","DOI":"10.1253\/circrep.CR-24-0170"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Tsuruda T, Nakada H, Yamamura Y, Matsuura Y, Ogata M, Tanaka M, et al. Basal inferoseptal segment is highly susceptible to deformation in the clinical spectrum of transthyretin-derived amyloid cardiomyopathy. <i>Eur Heart J Open<\/i> 2024; 4: oeae076, doi:10.1093\/ehjopen\/oeae076.","DOI":"10.1093\/ehjopen\/oeae076"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Naiki H, Sekijima Y, Ueda M, Ohashi K, Hoshii Y, Shimoda M, et al. Human amyloidosis, still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics. <i>Pathol Int<\/i> 2020; 70: 191\u2013198, doi:10.1111\/pin.12902.","DOI":"10.1111\/pin.12902"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mussinelli R, Salinaro F, Alogna A, Boldrini M, Raimondi A, Musca F, et al. Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. <i>Ann Noninvasive Electrocardiol<\/i> 2013; 18: 271\u2013280, doi:10.1111\/anec.12036.","DOI":"10.1111\/anec.12036"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Zhao L, Li J, Tian Z, Fang Q. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis. <i>J Cardiol<\/i> 2016; 68: 426\u2013430, doi:10.1016\/j.jjcc.2015.11.004.","DOI":"10.1016\/j.jjcc.2015.11.004"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99 mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. <i>J Am Coll Cardiol<\/i> 2005; 46: 1076\u20131084, doi:10.1016\/j.jacc.2005.05.073.","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr<\/i> 2015; 28: 1\u201339.e14, doi:10.1016\/j.echo.2014.10.003.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 233\u2013270, doi:10.1093\/ehjci\/jev014.","DOI":"10.1093\/ehjci\/jev014"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. <i>Am J Cardiol<\/i> 1986; 57: 450\u2013458, doi:10.1016\/0002-9149(86)90771-x.","DOI":"10.1016\/0002-9149(86)90771-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Liu D, Hu K, Nordbeck P, Ertl G, St\u00f6rk S, Weidemann F. Longitudinal strain bull\u2019s eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy. <i>Eur J Med Res<\/i> 2016; 21: 21, doi:10.1186\/s40001-016-0216-y.","DOI":"10.1186\/s40001-016-0216-y"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: Consensus Document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. <i>Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 1\u201311, doi:10.1093\/ehjci\/jeu184.","DOI":"10.1093\/ehjci\/jeu184"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, et al. Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. <i>JACC Cardiovasc Imaging<\/i> 2020; 13: 69\u201380, doi:10.1016\/j.jcmg.2019.03.026.","DOI":"10.1016\/j.jcmg.2019.03.026"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: Results from the International T1 Multicenter cardiovascular magnetic resonance study. <i>J Cardiovasc Magn Reson<\/i> 2014; 16: 69, doi:10.1186\/s12968-014-0069-x.","DOI":"10.1186\/s12968-014-0069-x"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance: 2020 update. <i>J Cardiovasc Magn Reson<\/i> 2020; 22: 19, doi:10.1186\/s12968-020-00610-6.","DOI":"10.1186\/s12968-020-00610-6"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. <i>Circ J<\/i> 2025; 89: 1278\u20131444, doi:10.1253\/circj.CJ-25-0002.","DOI":"10.1253\/circj.CJ-25-0002"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Garcia-Pavia P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, et al. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. <i>Eur J Heart Fail<\/i> 2021; 23: 895\u2013905, doi:10.1002\/ejhf.2198.","DOI":"10.1002\/ejhf.2198"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Kositanurit W, Theerasuwipakorn N, Vorasettakarnkij Y, Ponkanist K, Lerdkhonsan C, Tumkosit M, et al. Reference values of myocardial native T1 and extracellular volume in patients without structural heart disease and had negative 3T cardiac magnetic resonance adenosine stress test. <i>IJC Heart Vasc<\/i> 2023; 45: 101181, doi:10.1016\/j.ijcha.2023.101181.","DOI":"10.1016\/j.ijcha.2023.101181"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Tsuruda T, Ota T, Terada T, Nakada H, Ogata M, Tanaka M, et al. Basal inferoseptal longitudinal strain deformation may indicate early cardiac involvement in wild-type carpal ATTR. <i>ESC Heart Fail<\/i> 2026; 13: xvag055, doi:10.1093\/eschf\/xvag055.","DOI":"10.1093\/eschf\/xvag055"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tsuruda T, Kodama N, Tanahashi T, Suiko Y, Yamamoto K, Komaki S, et al. A single-kindred cluster of Val122Ile transthyretin amyloid cardiomyopathy: Subclinical case series of three Japanese patients. <i>Intern Med<\/i> 2026, doi:10.2169\/internalmedicine.6926-25.","DOI":"10.2169\/internalmedicine.6926-25"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Usuku H, Yamamoto E, Imamura K, Higashi R, Nozuhara A, Oike F, et al. Usefulness of regional longitudinal strain to identify transthyretin amyloid cardiomyopathy. <i>Circ Rep<\/i> 2025; 8: 495\u2013497, doi:10.1253\/circrep.CR-25-0269.","DOI":"10.1253\/circrep.CR-25-0269"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, et al. Native T1 and extracellular volume in transthyretin amyloidosis. <i>JACC Cardiovasc Imaging<\/i> 2019; 12: 810\u2013819, doi:10.1016\/j.jcmg.2018.02.006.","DOI":"10.1016\/j.jcmg.2018.02.006"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Dorbala S, Vangala D, Bruyere J Jr, Quarta C, Kruger J, Padera R, et al. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. <i>JACC Heart Fail<\/i> 2014; 2: 358\u2013367, doi:10.1016\/j.jchf.2014.03.009.","DOI":"10.1016\/j.jchf.2014.03.009"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, et al. Prognosis of transthyretin cardiac amyloidosis without heart failure symptoms. <i>JACC: CardioOncol<\/i> 2022; 4: 442\u2013454, doi:10.1016\/j.jaccao.2022.07.007.","DOI":"10.1016\/j.jaccao.2022.07.007"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Porcari A, Cappelli F, Nitsche C, Tomasoni D, Sinigiani G, Longhi S, et al. SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2024; 83: 2411\u20132422, doi:10.1016\/j.jacc.2024.03.429.","DOI":"10.1016\/j.jacc.2024.03.429"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Arbustini E, Merlini G. Early identification of transthyretin-related hereditary cardiac amyloidosis. <i>JACC: Cardiovascular Imaging<\/i> 2014; 7: 511\u2013514, doi:10.1016\/j.jcmg.2014.03.007.","DOI":"10.1016\/j.jcmg.2014.03.007"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: A practical approach. <i>JACC Cardiovasc Imaging<\/i> 2020; 13: 1368\u20131383, doi:10.1016\/j.jcmg.2019.07.015.","DOI":"10.1016\/j.jcmg.2019.07.015"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Rafiee MJ, Eyre K, Leo M, Benovoy M, Friedrich MG, Chetrit M. Comprehensive review of artifacts in cardiac MRI and their mitigation. <i>Int J Cardiovasc Imaging<\/i> 2024; 40: 2021\u20132039, doi:10.1007\/s10554-024-03234-4.","DOI":"10.1007\/s10554-024-03234-4"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/9\/8_CR-26-0158\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:25:44Z","timestamp":1789183544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/9\/8_CR-26-0158\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0158","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"CR-26-0158"}}